Effect of Low Molecular Weight Heparin on Survival of Stage I, II or IIIA Non Small Cell Lung Cancer. A Multicenter, Open, Randomized Controlled Trial.
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Embolism and thrombosis; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms TILT
- 15 Sep 2016 Last checked against ClinicalTrials.gov record.
- 01 Sep 2016 Status changed from active, no longer recruiting to completed.
- 17 Dec 2010 Planned end date changed from 1 Jun 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.